Ligand Pharmaceuticals Incorporated (LGND)

NasdaqGM Currently up 116.74 (+159.69%) in today's trading session

Track congressional stock trades in Ligand Pharmaceuticals Incorporated (LGND). Analyze trading activity from Nancy Pelosi and other members of Congress with real-time financial disclosure data, interactive price charts, and detailed transaction records.

Ligand Pharmaceuticals Incorporated is currently trading at $189.84, positioned at 72% of its 52-week range ($93.58 – $227.92). View which politicians have recently bought or sold LGND and how their trades align with market movements.

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio in real-time with just one click on eToro.

Free asset at sign up • Eligible regions only
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$189.84
24h Change
+116.74 (+159.69%)
52 Week Range
$93.58$227.92
View on NASDAQ

Ligand Pharmaceuticals Incorporated Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for LGND

Select to highlight on chart
0 transactions
Compliance: 100%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$3.86B

Volume

44.2K

Beta

1.03

P/E Ratio

31.50

Fundamentals

EPS

$6.14

Div. Yield

Open

$193.50

Day Range

$193.06 — $194.01

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Todd C. Davis
IPO Date
1992-11-18

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, wh...

Earnings

Next Report

Q1 2026

14 May

EPS Est.

$1.84

Rev. Est.

$59.1M

Days Until

45

Recent Quarters

Q4 202526 Feb
EPS$2.02
Beat 38.4%
Q3 20256 Nov
EPS$3.09
Beat 56.9%
Q2 20257 Aug
EPS$1.60
Beat 3.9%
Q1 20258 May
EPS$1.33
Beat 2.3%
Q4 202427 Feb
EPS$-1.64
Miss 219.7%
Q3 20247 Nov
EPS$-0.39
Miss 152.0%
Q2 20246 Aug
EPS$1.40
Beat 27.3%
Q1 20247 May
EPS$1.20
Beat 6.2%
Q4 202327 Feb
EPS$1.05
Beat 81.0%
Q3 20238 Nov
EPS$1.02
Beat 50.0%
Q2 20238 Aug
EPS$1.42
Beat 86.8%
Q1 20234 May
EPS$2.28
Beat 156.2%
Q4 202222 Feb
EPS$1.36
Beat 10.6%
Q3 20227 Nov
EPS$0.41
Miss 8.9%
Q2 20228 Aug
EPS$0.34
Miss 37.0%
Q1 20224 May
EPS$0.58
Miss 4.9%
Q4 202117 Feb
EPS$1.80
Beat 30.4%
Q3 20219 Nov
EPS$1.58
Beat 54.9%
Q2 202129 Jul
EPS$1.63
Beat 19.9%
Q1 20213 May
EPS$1.41
Beat 24.8%
Q4 20203 Feb
EPS$1.62
Beat 51.4%
Q3 202030 Oct
EPS$1.04
Miss 1.9%
Q2 20203 Aug
EPS$1.00
Beat 31.6%
Q1 20206 May
EPS$0.89
Beat 45.9%
Q4 20196 Feb
EPS$0.71
Beat 4.4%
Q3 20195 Nov
EPS$0.49
Miss 24.6%
Q2 201930 Jul
EPS$0.68
Beat 11.5%
Q1 20192 May
EPS$1.16
Miss 95.9%
Q4 20187 Feb
EPS$1.70
Beat 33.9%
Q3 20188 Nov
EPS$1.32
Beat 33.3%
Q2 20186 Aug
EPS$2.59
Beat 10.7%
Q1 20188 May
EPS$1.55
Beat 20.2%
Q4 201721 Feb
EPS$1.31
Beat 23.6%
Q3 20179 Nov
EPS$0.69
Beat 15.0%
Q2 20177 Aug
EPS$0.67
Beat 67.5%
Q1 20179 May
EPS$0.57
Miss 6.6%
Q4 201623 Feb
EPS$0.74
Miss 43.1%
Q3 20163 Nov
EPS$0.62
Beat 6.9%
Q2 20164 Aug
EPS$0.50
Beat 28.2%
Q1 20164 May
EPS$0.97
Beat 51.6%
Q4 201510 Feb
EPS$0.66
Beat 20.0%
Q3 20159 Nov
EPS$0.56
Beat 33.3%
Q2 20154 Aug
EPS$1.81
Beat 8.4%
Q1 201511 May
EPS$0.33
Beat 22.2%
Q4 20149 Feb
EPS$0.60
Beat 0.0%
Q3 201427 Oct
EPS$0.36
Beat 16.1%
Q2 20144 Aug
EPS$0.24
Beat 60.0%
Q1 20147 May
EPS$0.35
Beat 40.0%
Q4 201311 Feb
EPS$0.36
Beat 80.0%
Q3 201330 Oct
EPS$0.12
Beat 71.4%
Q2 20131 Aug
EPS$0.07
Beat 40.0%
Q1 20138 May
EPS$0.15
Beat 25.0%
Q4 201213 Feb
EPS$0.27
Beat 92.9%
Q3 20125 Nov
EPS$-0.01
Miss 76.1%
Q2 20128 Aug
EPS$-0.20
Miss 1011.1%
Q1 20122 May
EPS$-0.03
Miss 80.0%
Q4 20117 Feb
EPS$0.24
Beat 242.9%
Q3 20118 Nov
EPS$-0.09
Miss 1000.2%
Q2 20118 Aug
EPS$-0.05
Miss 145.4%
Q1 201110 May
EPS$0.48
Beat 860.0%
Q4 201015 Feb
EPS$0.12
Beat 500.0%
Q3 20109 Nov
EPS$-3.60
Miss 11900.0%
Q2 20105 Aug
EPS$-0.01
Miss 99.9%
Q1 20105 May
EPS$-0.12
Beat 33.3%
Q4 20099 Feb
EPS$0.06
Beat 150.0%
Q3 20095 Nov
EPS$0.06
Beat 125.0%
Q2 20093 Aug
EPS$-0.30
Beat 26.8%
Q1 20096 May
EPS$-0.30
Miss 11.1%
Q4 200812 Feb
EPS$-4.56
Miss 1069.2%
Q3 20086 Nov
EPS$-0.60
Miss 100.0%
Q2 200831 Jul
EPS$-0.30
Beat 28.6%
Q1 20081 May
EPS$-0.60
Miss 122.2%
Q4 200720 Feb
EPS$0.36
Beat 500.0%
Q3 20078 Nov
EPS$0.06
Beat 150.0%
Q2 20078 Aug
EPS$0.01
Beat 103.6%
Q1 200710 May
EPS$16.32
Miss 2.2%
Q4 200615 Mar
EPS$8.52
Miss 16.0%
Q3 200614 Nov
EPS$-1.26
Miss 90.9%
Q2 20069 Aug
EPS$-1.22
Q2 20069 Aug
EPS$-0.96
Miss 77.8%
Q4 200516 Mar
EPS$-0.24
Beat 55.6%
Q3 20059 Dec
EPS$-1.50
Q3 20059 Dec
EPS$-0.51
Q3 200518 Nov
EPS$-1.44
Miss 69.4%
Q4 200415 Feb
EPS$1.02
Miss 60.0%
Q3 20049 Nov
EPS$-0.54
Miss 800.0%
Q2 20043 Aug
EPS$-1.14
Miss 216.7%
Q1 20045 May
EPS$-1.08
Miss 208.6%
Q4 20033 Mar
EPS$0.60
Beat 252.9%
Q3 200331 Oct
EPS$-0.96
Miss 71.4%
Q2 200328 Jul
EPS$-1.02
Miss 22.9%
Q1 200324 Apr
EPS$-1.32
Miss 91.3%
Q4 200225 Feb
EPS$-0.54
Miss 2800.1%
Q3 200212 Nov
EPS$-0.60
Miss 900.0%
Q2 200213 Aug
EPS$-1.02
Miss 88.9%
Q1 20023 May
EPS$-0.42
Miss 600.0%
Q4 200111 Mar
EPS$-0.54
Beat 22.9%
Q3 200126 Oct
EPS$-0.78
Beat 7.1%
Q2 20011 Aug
EPS$-1.08
Beat 10.0%
Q1 20017 May
EPS$-1.18
Q1 200130 Apr
EPS$-1.20
Miss 5.3%
Q3 200014 Nov
EPS$-1.58
Q2 200014 Aug
EPS$-1.78
Q1 200015 May
EPS$-1.67
Q4 199910 Mar
EPS$-2.88
Miss 113.3%
Q3 199915 Nov
EPS$-2.34
Miss 25.8%
Q2 199916 Aug
EPS$-2.40
Miss 207.7%
Q1 199913 May
EPS$-1.92
Miss 6.7%
Q4 199830 Mar
EPS$-3.54
Miss 190.2%
Q3 199818 Nov
EPS$-2.40
Miss 95.1%
Q2 199814 Aug
EPS$-2.70
Miss 20.0%
Q1 199818 May
EPS$-2.10
Beat 2.8%
Q4 19975 Feb
EPS$-0.54
Beat 51.4%
Q3 199713 Nov
EPS$-2.10
Miss 16.7%
Q2 199714 Aug
EPS$-1.92
Miss 3.2%
Q1 199714 May
EPS$-1.92
Miss 8.5%
Q4 199631 Mar
EPS$-2.28
Miss 21.3%
Q3 19968 Nov
EPS$-1.80
Miss 1.7%
Q2 199614 Aug
EPS$-2.16
Miss 30.9%
Q1 19968 May
EPS$-1.50
Beat 5.7%
Q4 199528 Mar
EPS$-1.86
Beat 0.0%
Q3 199514 Nov
EPS$-1.92
Miss 113.3%
Q2 199515 Aug
EPS$-1.14
Beat 86.6%
Q1 199515 May
EPS$-1.86
Beat 29.6%
Q4 199416 Feb
EPS$-2.16
Beat 16.3%
Q3 199425 Oct
EPS$-2.52
Beat 13.7%
Q2 199415 Aug
EPS$-3.06
Miss 18.6%
Q1 199416 May
EPS$-2.88
Miss 7.5%
Q4 199316 Mar
EPS$-1.98
Beat 12.4%
Q3 199315 Nov
EPS$-2.46
Miss 21.8%
Q2 199314 Aug
EPS$-2.34
Miss 25.8%
Q1 199315 May
EPS$-1.50
Beat 19.4%
Q1 199310 May
EPS$-0.54
Beat 71.9%

Dividends

Dividend History

2 Jul 2010
Amount $0.4560
3 Apr 2007
Amount $9.3575

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations
Pelosi TrackerJoin our Discord © 2026 - All rights reserved. This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.